Immunocore Holdings (IMCR) Goodwill & Intangibles (2022 - 2023)
Immunocore Holdings (IMCR) posted Goodwill & Intangibles of $513058.9 for Q2 2023, up 6.69% sequentially from $480900.6 in Q4 2022.
Powered by 
Analysis
Immunocore Holdings (IMCR) Goodwill & Intangibles (2022 - 2023) Analysis & Trends
Immunocore Holdings has reported Goodwill & Intangibles for 2 years, with the latest figure at $513058.9 in Q2 2023.
- Quarterly Goodwill & Intangibles changed N/A year-over-year to $513058.9 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $513058.9 (changed N/A YoY) and the FY2022 annual result came in at $480900.6, changed N/A from the prior year.
- Goodwill & Intangibles advanced to $513058.9 in Q2 2023 per IMCR's latest filing, from $480900.6 in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $513058.9 in Q2 2023 and troughed at $480900.6 in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Immunocore Holdings | 1.85 Bn | 965.54 Mn | 114.84 Mn |